---
figid: PMC5594453__12943_2017_720_Fig3_HTML
figtitle: Signaling pathways that are activated by TMEM16A in cancer
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Canis lupus familiaris
- Polyura schreiber
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Canis lupus familiaris
- Drosophila melanogaster
pmcid: PMC5594453
filename: 12943_2017_720_Fig3_HTML.jpg
figlink: /pmc/articles/PMC5594453/figure/Fig3/
number: F3
caption: The signaling pathways that are activated by TMEM16A in cancer. TMEM16A directly
  interacts with EGFR [], and promotes EGFR phosphorylation, which activates the AKT/SRC/ERK1/2
  signaling []. In addition, TMEM16A increases autocrine secretion of EGF in breast
  cancer cells []. TMEM16A directly interacts with IP3R, and increased Ca2+ release
  from the ER []. TMEM16A activates CaMKII by increasing intracellular Ca2+ concentrations,
  and CaMKII subsequently activates the AKT/SRC/ERK1/2 signaling []. TMEM16A also
  activates the Ras-Raf-Mek-ERK1/2 signaling pathway in UM-SCC1 HNSCC cells and T24
  bladder cells []. In SMMC-7721 human hepatoma cells, TMEM16A activates the p38 signaling
  pathway []. TMEM16A activates the NFκB signaling pathway and promotes the gene transcription
  in glioma cells []. +, activates the signaling pathway.?, the mechanisms of how
  TMEM16A activates the signaling pathway are unknown
papertitle: Cell-specific mechanisms of TMEM16A Ca2+-activated chloride channel in
  cancer.
reftext: Hui Wang, et al. Mol Cancer. 2017;16:152.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9709136
figid_alias: PMC5594453__F3
figtype: Figure
redirect_from: /figures/PMC5594453__F3
ndex: b6d03cf7-dec7-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5594453__12943_2017_720_Fig3_HTML.html
  '@type': Dataset
  description: The signaling pathways that are activated by TMEM16A in cancer. TMEM16A
    directly interacts with EGFR [], and promotes EGFR phosphorylation, which activates
    the AKT/SRC/ERK1/2 signaling []. In addition, TMEM16A increases autocrine secretion
    of EGF in breast cancer cells []. TMEM16A directly interacts with IP3R, and increased
    Ca2+ release from the ER []. TMEM16A activates CaMKII by increasing intracellular
    Ca2+ concentrations, and CaMKII subsequently activates the AKT/SRC/ERK1/2 signaling
    []. TMEM16A also activates the Ras-Raf-Mek-ERK1/2 signaling pathway in UM-SCC1
    HNSCC cells and T24 bladder cells []. In SMMC-7721 human hepatoma cells, TMEM16A
    activates the p38 signaling pathway []. TMEM16A activates the NFκB signaling pathway
    and promotes the gene transcription in glioma cells []. +, activates the signaling
    pathway.?, the mechanisms of how TMEM16A activates the signaling pathway are unknown
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egf
  - Egfr
  - Ano1
  - ras
  - Hras
  - Kras
  - Rem1
  - Akt1
  - Nfkbib
  - Cdc37
  - Lsp1
  - Nfkb1
  - Pold2
  - Cd40
  - Dctn2
  - Rela
  - Gorasp1
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Zhx2
  - Camk2a
  - Camk2b
  - Src
  - Mdk
  - Mapk3
  - Mapk1
  - EGF
  - EGFR
  - ANO1
  - KRAS
  - HRAS
  - NRAS
  - AKT1
  - AKT2
  - AKT3
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - NFKB1
  - RELB
  - REL
  - NFKB2
  - CAMK2G
  - SRC
  - FGR
  - FYN
  - YES1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MAPK3
  - Syt1
  - Camk2d
  - Ras64B
  - Ras85D
  - Akt
  - ca
  - Hrb27C
  - betaTub60D
  - Rpt5
  - DCTN2-p50
  - dl
  - wash
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - p38a
  - Hrb87F
  - p38c
  - Raf
  - Dif
  - Rel
  - CaMKII
  - Src42A
  - Csk
  - Src64B
  - Dsor1
  - Mtk
  - rl
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
